We performed an updated metanalysis of RCTs in patients with HF to evaluate the effects of chronic administration of SGLT2-inhibitors on LV volumes, mass, ejection fraction (EF), and N-terminal pro-B-type natriuretic peptide (NTproBNP). This evidence concerns the gene SLC5A2 and hydrops fetalis.